We serve Chemical Name:tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate CAS:1245652-85-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate](https://a.dearchem.com/CAS2/1245652-85-0.png)
Chemical Name:tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate
CAS.NO:1245652-85-0
Synonyms:tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate
Molecular Formula:C27H30ClN7O2S
Molecular Weight:552.09100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:127.51000
Exact Mass:551.18700
LogP:6.42320
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate Use and application,tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate technical grade,usp/ep/jp grade.
Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate manufacturer J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate supplier Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate vendor He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. tert-butyl 4-[6-[[5-[(E)-2-(7-chloro-1H-indol-4-yl)ethenyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate factory As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.
